scholarly article | Q13442814 |
P2093 | author name string | Naoko Mizuno | |
Baikuntha Aryal | |||
Michael H Gerber | |||
V Ashutosh Rao | |||
Thomas G Biel | |||
Josè G Trevino | |||
P2860 | cites work | Loss of Mitochondrial Function Impairs Lysosomes. | Q38785393 |
Proteasomal and Autophagic Degradation Systems | Q39275553 | ||
The role of ATF4 stabilization and autophagy in resistance of breast cancer cells treated with Bortezomib | Q39856430 | ||
Bortezomib (VELCADE) in metastatic breast cancer: pharmacodynamics, biological effects, and prediction of clinical benefits | Q40359103 | ||
Enhanced Degradation of Misfolded Proteins Promotes Tumorigenesis. | Q41720019 | ||
Targeting autophagy in cancer | Q41912265 | ||
Mitochondrial dysfunction induced by a SH2 domain-targeting STAT3 inhibitor leads to metabolic synthetic lethality in cancer cells | Q47150116 | ||
The proteasome and proteasome inhibitors in multiple myeloma | Q47339695 | ||
Receptor oligomerization guides pathway choice between proteasomal and autophagic degradation. | Q48144486 | ||
Mitochondrial dysfunction activates lysosomal-dependent mitophagy selectively in cancer cells. | Q49304282 | ||
Metabolic effects of fasting on human and mouse blood in vivo. | Q49970544 | ||
Cargo recognition and degradation by selective autophagy. | Q50422083 | ||
A brief history of autophagy from cell biology to physiology and disease. | Q52568575 | ||
Changes in contraction, cytosolic Ca2+ and pH during metabolic inhibition and upon restoration of mitochondrial respiration in rat ventricular myocytes. | Q52867033 | ||
Co-localization of mutant p53 and amyloid-like protein aggregates in breast tumors | Q57084696 | ||
Mitochondrial metabolism and cancer | Q57842307 | ||
An agarose-acrylamide composite native gel system suitable for separating ultra-large protein complexes | Q81889891 | ||
p53 protein aggregation promotes platinum resistance in ovarian cancer | Q85645987 | ||
Pharmacological targeting of mutant p53 | Q92914764 | ||
Genevestigator v3: a reference expression database for the meta-analysis of transcriptomes | Q21342839 | ||
Guidelines for the use and interpretation of assays for monitoring autophagy | Q21996341 | ||
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) | Q22676705 | ||
Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes | Q23757358 | ||
Micro-flow imaging: flow microscopy applied to sub-visible particulate analysis in protein formulations | Q24622866 | ||
Mito-tempol and dexrazoxane exhibit cardioprotective and chemotherapeutic effects through specific protein oxidation and autophagy in a syngeneic breast tumor preclinical model | Q27310238 | ||
A lysosome-centered view of nutrient homeostasis | Q28073435 | ||
Protein aggregation as a cellular response to oxidative stress induced by heme and iron | Q28395171 | ||
CBP/p300 Bromodomains Regulate Amyloid-like Protein Aggregation upon Aberrant Lysine Acetylation | Q28818241 | ||
Aggresomes, inclusion bodies and protein aggregation | Q29615253 | ||
A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme | Q33416266 | ||
The accumulation of misfolded proteins in the mitochondrial matrix is sensed by PINK1 to induce PARK2/Parkin-mediated mitophagy of polarized mitochondria | Q33638683 | ||
Phase II and pharmacodynamic study of autophagy inhibition using hydroxychloroquine in patients with metastatic pancreatic adenocarcinoma | Q33699665 | ||
The small heat shock protein B8 (HSPB8) confers resistance to bortezomib by promoting autophagic removal of misfolded proteins in multiple myeloma cells. | Q34227679 | ||
The antioxidant transcription factor Nrf2 negatively regulates autophagy and growth arrest induced by the anticancer redox agent mitoquinone | Q34251106 | ||
Combined autophagy and proteasome inhibition: a phase 1 trial of hydroxychloroquine and bortezomib in patients with relapsed/refractory myeloma | Q34372977 | ||
Combined autophagy and HDAC inhibition: a phase I safety, tolerability, pharmacokinetic, and pharmacodynamic analysis of hydroxychloroquine in combination with the HDAC inhibitor vorinostat in patients with advanced solid tumors | Q34372994 | ||
TBK1 kinase addiction in lung cancer cells is mediated via autophagy of Tax1bp1/Ndp52 and non-canonical NF-κB signalling | Q34500600 | ||
Autophagy and human disease: emerging themes | Q34620377 | ||
Engineering trimeric fibrous proteins based on bacteriophage T4 adhesins | Q34663520 | ||
Molecular chaperone GRP78 enhances aggresome delivery to autophagosomes to promote drug resistance in multiple myeloma. | Q35550181 | ||
Clinical significance of the expression of autophagy-associated marker, beclin 1, in breast cancer patients who received neoadjuvant endocrine therapy | Q35960231 | ||
Mutant p53 aggregates into prion-like amyloid oligomers and fibrils: implications for cancer. | Q36201740 | ||
Therapeutic Targeting of the Mitochondria Initiates Excessive Superoxide Production and Mitochondrial Depolarization Causing Decreased mtDNA Integrity | Q36234714 | ||
The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy | Q37246125 | ||
Genevestigator transcriptome meta-analysis and biomarker search using rice and barley gene expression databases | Q38508703 | ||
Cytosolic proteostasis through importing of misfolded proteins into mitochondria | Q38714671 | ||
Molecular definitions of autophagy and related processes. | Q38735356 | ||
P433 | issue | 6 | |
P304 | page(s) | 460 | |
P577 | publication date | 2020-06-15 | |
P1433 | published in | Cell Death and Disease | Q2197222 |
P1476 | title | Mitochondrial dysfunction generates aggregates that resist lysosomal degradation in human breast cancer cells | |
P478 | volume | 11 |
Search more.